|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 9/14 | (2006.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3237003 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15873812.0 |
| Date of filing the European patent application | 2015-12-24 | |
| (97) | Date of publication of the European application | 2017-11-01 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/000340 |
| Date | 2015-12-24 |
| (87) | Number | WO 2016/105542 |
| Date | 2016-06-30 |
| (30) | Number | Date | Country code |
| 201462096725 P | 2014-12-24 | US |
| (72) |
| (73) |
NexImmune, Inc ,
9119 Gaither Road, Gaithersburg, MD 20877,
US
|
| (54) | NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |
| NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |